Literature DB >> 25374810

Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.

Janina Müller-Deile1, Mario Schiffer1.   

Abstract

Proteinuria is a frequently detected symptom, found in 20% of pregnancies. A common reason for proteinuria in pregnancy is preeclampsia. To diagnose preeclampsia clinically and to get new insights into the pathophysiology of the disease it is at first essential to be familiar with conditions in normal pregnancy. Animal models and biomarkers can help to learn more about disease conditions and to find new treatment strategies. In this article we review the changes in kidney function during normal pregnancy and the differential diagnosis of proteinuria in pregnancy. We summarize different pathophysiological theories of preeclampsia with a special focus on the renal facets of the disease. We describe the current animal models and give a broad overview of different biomarkers that were reported to predict preeclampsia or have a prognostic value in preeclampsia cases. We end with a summary of treatment options for preeclampsia related symptoms including the use of plasmapheresis as a rescue therapy for so far refractory preeclampsia. Most of these novel biomarkers for preeclampsia are not yet implemented in clinical use. Therefore, we recommend using proteinuria (measured by UPC ratio) as a screening parameter for preeclampsia. Delivery is the only curative treatment for preeclampsia. In early preeclampsia the primary therapy goal is to prolong pregnancy until a state were the child has an acceptable chance of survival after delivery.

Entities:  

Keywords:  Biomarkers; Preeclampsia; Pregnancy; Proteinuria; Treatment

Year:  2014        PMID: 25374810      PMCID: PMC4220349          DOI: 10.5527/wjn.v3.i4.169

Source DB:  PubMed          Journal:  World J Nephrol        ISSN: 2220-6124


  121 in total

1.  Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia.

Authors:  P M Bosio; S Cannon; P J McKenna; C O'Herlihy; R Conroy; H Brady
Journal:  BJOG       Date:  2001-07       Impact factor: 6.531

2.  Increased cystatin C expression in the pre-eclamptic placenta.

Authors:  Karl Kristensen; I Larsson; S R Hansson
Journal:  Mol Hum Reprod       Date:  2007-01-16       Impact factor: 4.025

3.  Adrenomedullin in pregnancy.

Authors:  R Di Iorio; E Marinoni; D Scavo; C Letizia; E V Cosmi
Journal:  Lancet       Date:  1997-02-01       Impact factor: 79.321

4.  Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes.

Authors:  Rebecca R Foster; Rachel Hole; Karen Anderson; Simon C Satchell; Richard J Coward; Peter W Mathieson; David A Gillatt; Moin A Saleem; David O Bates; Steven J Harper
Journal:  Am J Physiol Renal Physiol       Date:  2003-03-04

5.  Day-to-day variability in spot urine albumin-creatinine ratio.

Authors:  Chetana N Naresh; Andrew Hayen; Alexander Weening; Jonathan C Craig; Steven J Chadban
Journal:  Am J Kidney Dis       Date:  2013-08-16       Impact factor: 8.860

6.  Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients.

Authors:  Arnold B Alper; Yeonjoo Yi; Mahfuz Rahman; Larry S Webber; Laura Magee; Peter von Dadelszen; Gabriella Pridjian; Abimbola Aina-Mumuney; George Saade; Jamie Morgan; Bahij Nuwayhid; Michael Belfort; Jules Puschett
Journal:  Am J Perinatol       Date:  2010-11-18       Impact factor: 1.862

7.  PIERS proteinuria: relationship with adverse maternal and perinatal outcome.

Authors:  Beth Payne; Laura A Magee; Anne-Marie Côté; Jennifer A Hutcheon; Jing Li; Phillipa M Kyle; Jennifer M Menzies; M Peter Moore; Claire Parker; Barbra Pullar; Peter von Dadelszen; Barry N Walters; P von Dadelszen; L A Magee; M J Douglas; K R Walley; J A Russell; S K Lee; A Gruslin; G N Smith; A M Côté; J-M Moutquin; M A Brown; G Davis; B N Walters; N Sass; T Duan; J Zhou; S Mahajan; A Noovao; L A McCowan; P Kyle; M P Moore; S Z Bhutta; Z A Bhutta; D W Steyn; F Broughton Pipkin; P Loughna; S Robson; M de Swiet; J J Walker; W A Grobman; M D Lindheimer; J M Roberts; J Mark Ansermino; Samantha Benton; Geoff Cundiff; Dany Hugo; K S Joseph; Sayrin Lalji; Jing Li; Paula Lott; Annie B Ouellet; Dorothy Shaw; D Keith Still; George Tawagi; Brenda Wagner; Christine Biryabarema; Florence Mirembe; Annettee Nakimuli; Eleni Tsigas; Mario Merialdi; Mariana Widmer
Journal:  J Obstet Gynaecol Can       Date:  2011-06

8.  Circadian rhythm of proteinuria: consequences of the use of urinary protein:creatinine ratios.

Authors:  M G Koopman; R T Krediet; G C Koomen; J Strackee; L Arisz
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

9.  Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia.

Authors:  Kristina Biskupska Bodova; Kamil Biringer; Karol Dokus; Jela Ivankova; Jan Stasko; Jan Danko
Journal:  Dis Markers       Date:  2011       Impact factor: 3.434

10.  Plasmapheresis in acute Fatty liver of pregnancy: an effective treatment.

Authors:  Mohammad Reza Seyyed Majidi; Jamshid Vafaeimanesh
Journal:  Case Rep Obstet Gynecol       Date:  2013-01-31
View more
  12 in total

1.  Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy.

Authors:  Mark W Cunningham; Jan M Williams; Lorena Amaral; Nathan Usry; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Hypertension       Date:  2016-10-03       Impact factor: 10.190

Review 2.  The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia?

Authors:  Olive P Khaliq; Tadashi Konoshita; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-07-10       Impact factor: 5.369

Review 3.  Preeclampsia: long-term consequences for vascular health.

Authors:  Lorena M Amaral; Mark W Cunningham; Denise C Cornelius; Babbette LaMarca
Journal:  Vasc Health Risk Manag       Date:  2015-07-15

4.  Serum NF-κBp65, TLR4 as Biomarker for Diagnosis of Preeclampsia.

Authors:  Zhao Litang; Wang Hong; Zhang Weimin; Tian Xiaohui; Sun Qian
Journal:  Open Med (Wars)       Date:  2017-12-02

5.  Biochemical Assessment of Renal and Liver Function among Preeclamptics in Lagos Metropolis.

Authors:  Oloruntoba Ayodele Ekun; Oluwatumininu Mary Olawumi; Christian Chigozie Makwe; Nkeiruka Ogochukwu Ogidi
Journal:  Int J Reprod Med       Date:  2018-07-31

6.  Effect of Nanoherbal Andaliman (Zanthoxylum acanthopodium) and Extra Virgin Olive Oil Combination on Preeclamptic Rats Liver Histology.

Authors:  Putri Cahaya Situmorang; Syafruddin Ilyas; Salomo Hutahaean; Rosidah Rosidah
Journal:  Open Access Maced J Med Sci       Date:  2019-07-14

7.  The association of MOV10 polymorphism and expression levels with preeclampsia in the Chinese Han population.

Authors:  Qian Tang; Ling Wang; Renmei Cai; Lu Zhang; Xiaoxiao Zhang; Xuemei Liu; Shiguo Liu
Journal:  Mol Genet Genomic Med       Date:  2020-12-02       Impact factor: 2.183

8.  The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators.

Authors:  Magnus Gram; Ulrik Dolberg Anderson; Maria E Johansson; Anneli Edström-Hägerwall; Irene Larsson; Maya Jälmby; Stefan R Hansson; Bo Åkerström
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

9.  Serum and urine vitamin D metabolite analysis in early preeclampsia.

Authors:  J A Tamblyn; C Jenkinson; D P Larner; M Hewison; M D Kilby
Journal:  Endocr Connect       Date:  2017-12-07       Impact factor: 3.335

10.  Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish.

Authors:  Janina Müller-Deile; Patricia Schröder; Lynne Beverly-Staggs; Rebecca Hiss; Jan Fiedler; Jenny Nyström; Thomas Thum; Hermann Haller; Mario Schiffer
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.